Clinical Gastroenterology and Hepatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Automated Reporting System for Colonoscopy Quality: Lessons in Implementation
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - October 5, 2021 Category: Gastroenterology Authors: Nuzhat A. Ahmad, Shivan J. Mehta Tags: Practice Management Source Type: research

Patients with Pouchitis Demonstrate a Significant Cost Burden in the First Two Years after Ileal Pouch-Anal Anastomosis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - October 2, 2021 Category: Gastroenterology Authors: Edward L. Barnes, Michael D. Kappelman, Xian Zhang, Millie D. Long, Robert S. Sandler, Hans H. Herfarth Source Type: research

Duodenal Mucosal Barrier in Functional Dyspepsia
In addition to gastric sensorimotor dysfunctions, functional dyspepsia (FD) is also variably associated with duodenal micro-inflammation and epithelial barrier dysfunction, the pathogenesis and clinical significance of which are unknown. Our hypothesis was that miRNAs and/or inflammation degrade epithelial barrier proteins resulting in increased duodenal mucosal permeability in FD. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - October 1, 2021 Category: Gastroenterology Authors: Susrutha Puthanmadhom Narayanan, Daniel R. O ’Brien, Mayank Sharma, Thomas C. Smyrk, Rondell P. Graham, Madhusudan Grover, Adil E. Bharucha Source Type: research

Next Generation Academic Gastroenterology
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - October 1, 2021 Category: Gastroenterology Authors: John I. Allen, Sameer Berry Tags: Practice Management Source Type: research

Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn ’s Disease: ENTERPRISE Study
We report results from ENTERPRISE, a randomized, double-blind, phase 4 trial, evaluating 2 vedolizumab intravenous dosing regimens in patients with fistulizing CD. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 28, 2021 Category: Gastroenterology Authors: David A. Schwartz, Laurent Peyrin-Biroulet, Karen Lasch, Shashi Adsul, Silvio Danese Source Type: research

Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens
Most patients with small intestinal bacterial overgrowth (SIBO) produce hydrogen by fermentation of dietary carbohydrates; however, ∼30% of patients with SIBO are colonized with Archaea, anaerobic organisms that produce methane. SIBO is associated with a plethora of symptoms and conditions, but their diagnostic significance is unclear. We aimed to determine if specific symptoms and conditions are associated with methanogenic S IBO. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 28, 2021 Category: Gastroenterology Authors: Katelyn E. Madigan, Richa Bundy, Richard B. Weinberg Source Type: research

Reply
We thank Lv et  al1 for their interest and comments in our study. Underwater endoscopic mucosal resection (UEMR) is recently getting attention for its efficacy and safety for treatment of superficial nonampullary duodenal epithelial tumor (SNADET). Usefulness of UEMR for SNADET had been reported in several report s; however, previous studies had small sample size without evaluation of clinically relevant end points.2,3 Thus, we conducted a multicenter prospective study to evaluate the nonrecurrence rate of UEMR for SNADET using careful follow-up biopsy. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 27, 2021 Category: Gastroenterology Authors: Yasushi Yamasaki, Noriya Uedo Tags: Letter to the Editor Source Type: research

A response for a CGH Letter to the editor entitled “The application of underwater EMR for non-ampullary duodenal adenomas” (CGH-D-21-02009R1)
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 27, 2021 Category: Gastroenterology Authors: Yasushi Yamasaki, Noriya Uedo Source Type: research

Reply
We thank Dr Jindal for his interests in and comments on our study, which we address herein. First, not all chronic hepatitis B (CHB) patients with cirrhosis were indefinitely reimbursed for antiviral therapy by the national health insurance in Taiwan. For patients whose viremia did not exceed 2000 IU/mL or those without overt features of portal hypertension, the reimbursement was finite (up to 3 years in general) despite a clinical diagnosis of cirrhosis throughout the study period. Because our analysis was deliberately based on real-world data from consecutive patients who discontinued treatment as a routine practice, we ...
Source: Clinical Gastroenterology and Hepatology - September 26, 2021 Category: Gastroenterology Authors: Yao-Chun Hsu, Jia-Ling Wu, Mindie H. Nguyen Tags: Letter to the Editor Source Type: research

Quantify the Risk of Severe Hepatitis B Flare in a Real World Where Cessation of Nucleos(t)ide Analog is Routinely Practiced
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 26, 2021 Category: Gastroenterology Authors: Yao-Chun Hsu, Jia-Ling Wu, Mindie H. Nguyen Source Type: research

Keystone to secure safety after stopping nucleos(t)ide analogue therapy in chronic hepatitis B patients
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 25, 2021 Category: Gastroenterology Authors: Yen-Chun Liu, Wen-Juei Jeng, Chien-Hung Chen Source Type: research

Fatty pancreas is independently associated with subsequent diabetes mellitus development: A 10-year prospective cohort study
While the association between fatty pancreas and metabolic syndrome has been suggested in retrospective studies, long-term prospective data on the effect of fatty pancreas on various metabolic outcomes is lacking. We aimed to prospectively investigate the association between fatty pancreas and development of major metabolic outcomes. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 24, 2021 Category: Gastroenterology Authors: Ting Ting Chan, Yee Kit Tse, Rashid Nok Shun Lui, Grace Lai Hung Wong, Angel Mei Ling Chim, Alice Pik Shan Kong, Jean Woo, David Ka Wai Yeung, Jill M. Abrigo, Winnie Chiu Wing Chu, Vincent Wai Sun Wong, Raymond Shing Yan Tang Source Type: research

High Prevalence of Osteopathy in Chronic Pancreatitis: A  Cross-sectional Analysis From the PROCEED Study
Chronic pancreatitis (CP) is associated with osteopathy (osteoporosis or osteopenia). However, existing literature is mostly limited to retrospective or administrative studies that have not clearly defined the prevalence and risk factors. Our aim was to identify patient- and disease-related associations with osteopathy in a prospective cohort study of CP. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 23, 2021 Category: Gastroenterology Authors: Phil A. Hart, Dhiraj Yadav, Liang Li, Savi Appana, William Fisher, Evan Fogel, Chris E. Forsmark, Walter G. Park, Stephen Pandol, Mark D. Topazian, Stephen K. Van Den Eden, Santhi Swaroop Vege, David Bradley, Jose Serrano, Darwin L. Conwell, Consortium fo Source Type: research

High Prevalence of Osteopathy in Chronic Pancreatitis: A Cross-sectional Analysis from the PROCEED Study
Chronic pancreatitis (CP) is associated with osteopathy (osteoporosis or osteopenia). However, existing literature is mostly limited to retrospective or administrative studies that have not clearly defined the prevalence and risk factors. Our aim was to identify patient- and disease-related associations with osteopathy in a prospective cohort study of CP. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 23, 2021 Category: Gastroenterology Authors: Phil A. Hart, Dhiraj Yadav, Liang Li, Savi Appana, William Fisher, Evan Fogel, Chris E. Forsmark, Walter G. Park, Stephen Pandol, Mark D. Topazian, Stephen K. Van Den Eden, Santhi Swaroop Vege, David Bradley, Jose Serrano, Darwin L. Conwell, Consortium fo Source Type: research

Correction
Tayob N, Corley DA, Christie I, Almers L, Rahal AK, Richardson P, White DL, Davila J, Kanwal F, El-Serag, HB. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. Clin Gastroenterol Hepatol. 2021; 19:1443-1450.e6 (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - September 22, 2021 Category: Gastroenterology Source Type: research